Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: The Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges

Contemporary Clinical Trials

Volumn 32, Issue 1, 2011, Pages 74-85

  Farley, Timothy MM ^l   Meda, Nicolas ^a   Fao, Paulin ^a   Kyzerbo, Odette ^a   Gouem, Clarisse ^a   Somda, Paulin ^a   Hien, Hervé ^a   Ouedraogo, Patrice Elysée ^a   Kania, Dramane ^a   Sanou, Armande ^a   Kossiwavi, Ida Ayassou ^a   Sanogo, Bintou ^a   Ouedraogo, Moussa ^a   Siribie, Issa ^a   Valéa, Diane ^a   Ouedraogo, Sayouba ^a   Somé, Roseline ^a   Rouet, François ^a   Rollins, Nigel ^b   McFetridge, Lynne ^b   Naidu, Kevi ^b   Luchters, Stanley ^c   Reyners, Marcel ^c   Irungu, Eunice ^c   Katingima, Christine ^c   Mwaura, Mary ^c   Ouattara, Gina ^c   Mandaliya, Kishor ^c   Thiongo, Mary ^c   Wambua, Sammy ^c   Nduati, Ruth ^d   Kose, Judith ^d   Njagi, Ephantus ^d   Mwaura, Peter ^d   Newell, Marie Louise ^e   Mepham, Stephen ^e   Viljoen, Johannes ^e   Bland, Ruth ^e   Bazin, Brigitte ^f   Rekacewicz, Claire ^f   Taylor, Allan ^g   Flowers, Nicole ^g   Thigpen, Michael ^g   Fowler, Mary Glenn ^g   Jamieson, Denise ^g   Read, Jennifer S ^h   Bork, Kirsten ⁱ   Cames, Cécile ⁱ   Cournil, Amandine ⁱ   Claeys, Patricia ^j   Temmerman, Marleen ^j   Van de Perre, Philippe ^k   Becquart, Pierre ^k   Foulongne, Vincent ^k   Segondy, Michel ^k   de Vincenzi, Isabelle ^l   Gaillard, Philippe ^l   Habib, Ndema ^l   Landoulsi, Sihem ^l   more..

^a CENTRE MURAZ   (Burkina Faso)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c International Centre for Reproductive Health Kenya   (Kenya)

^d NARESA   (Kenya)

^e AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^f Agence Nationale de Recherches sur les SIDA et les Hépatites Virales   (France)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁱ INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^j GHENT UNIVERSITY   (Belgium)

^k UNIV MONTPELLIER   (France)

^l WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

Cohort study; Design; HIV AIDS; Mother to child transmission; Randomized controlled trial

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; ZIDOVUDINE;

AFRICA; ARTICLE; BREAST FEEDING; CLINICAL TRIAL; COHORT ANALYSIS; DELIVERY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; INFECTION PREVENTION; INTERVENTION STUDY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREGNANCY; PROSPECTIVE STUDY; SINGLE DRUG DOSE; SOUTH AFRICA; STUDY DESIGN; VIRUS TRANSMISSION;

EID: 78649904154     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.09.008     Document Type: Article

References (48)

1. De Cock K.M., Fowler M.G., Mercier E., et al. Prevention of mother-to-child HIV transmission in resource-poor countries-translating research into policy and practice. JAMA 2000, 283(9):1175-1182.
2. The PETRA Study Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda: a randomised, double-blind, placebo-controlled trial. Lancet 2002, 359(9313):1178-1186.
3. Leroy V., Karon J.M., Alioum A., et al. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002, 16(4):631-641.
4. Guay L.A., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354(9181):795-802.
5. Thior I., Lockman S., Smeaton L.M., et al. Breastfeeding plus infant zidovudine prophylaxis for 6months vs formula feeding plus infant zidovudine for 1month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006, 296(7):794-805.
6. Dabis F., Bequet L., Ekouevi D.K., et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005, 19(3):309-318.
7. European Collaborative Study HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001, 15(6):761-770.
8. Cooper E.R., Charurat M., Burns D.N., Blattner W., Hoff R. Trends in antiretroviral therapy and mother-infant transmission of HIV. J Acquir Immune Defic Syndr 2000, 24:45-47.
9. Cooper E.R., Charurat M., Mofenson L., et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002, 29(5):484-494.
10. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999, 353(9158):1035-1039. The European Mode of Delivery Collaboration.
11. The International Perinatal HIV Group The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1-a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999, 340(13):977-987.
12. Nduati R., John G., Mbori-Ngacha D., et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000, 283(9):1167-1174.
13. Breastfeeding and HIV International Transmission Study Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004, 189(12):2154-2166.
14. Kumwenda N.I., Hoover D.R., Mofenson L.M., et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008, 359(2):119-129.
15. SWEN Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008, 372(9635):300-313.
16. Van der Horst C., Chasela C., Ahmed Y., et al. Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials 2009, 30(1):24-33.
17. Vyankandondera J., Luchters S., Hassink E., et al. Reducing risk of HIV-1 transmission from mother to infant through breastfeeding using antiretroviral prophylaxis in infants (SIMBA-study). (Abstract LB7). IAS Conference on HIV Pathogenesis and Treatment, Paris, France 2003.
18. WHO Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision) http://who.int/hiv/pub/arv/adult/en/index.html.
19. Department for Health and Human Services. Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services 2009. http://www.aidsinfo.nih.gov/contentfiles/adultandadolescentgl.pdf.
20. Rouet F., Chaix M.L., Nerrienet E., et al. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr 2007, 45(4):380-388.
21. Rouet F., Foulongne V., Viljoen J., et al. Comparison of the generic HIV viral load((R)) assay with the amplicor HIV-1 monitor v1.5 and nuclisens HIV-1 EasyQ((R)) v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: The Kesho Bora preparatory study. J Virol Methods 2010, 163(2):253-257.
22. DAIDS/NIAID/NIH. Division of AIDS tables for grading severity of adverse experiences, 1992. http://rcc.tech-res.com/Document/safetyandpharmacovigilance/ToxicityTables_Pediatric_Over3MonthsAge_v03.pdf.
23. Statistical Analysis System (SAS) Version 9.1. Cary, NC, USA: SAS Institute.
24. Viljoen J.I., Danaviah S., Pillay S., et al. Analytical performances of the Generic HIV Charge Virale® kit for HIV-1 RNA quantification on dried blood and plasma spots (DBS/DPS) in Durban, South Africa. 15th Conference on AIDS and STDs in Africa, Dakar, Senegal 2008, pour le Groupe de Travail Kesho Bora, abstract 662/SOA07.
25. Murphy D.A., Greenwell L., Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health 2002, 36(1):97-111.
26. Wagner G.J., Remien R.H., Carballo-Dieguez A., Dolezal C. Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples. AIDS Care 2002, 14(1):105-109.
27. WHO Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings 2004, http://who.int/hiv/pub/mtct/guidelinesarv/en/index.html.
28. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. WHO 2006. http://www.who.int/hiv/pub/mtct/antiretroviral/en/index.html.
29. Food and Drug Administration Public Health Advisory for Nevirapine (Viramune). Silver Spring, MD, USA http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051674.htm.
30. Lallemant M., Jourdain G., Le Coeur S., et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000, 343(14):982-991.
31. McIntyre J.A., Hopley M., Moodley D., et al. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med 2009, 6(10):e1000172.
32. WHO/UNICEF/UNAIDS/UNFPA HIV and infant feeding: a guide for health care managers and supervisors 2003, (78 pp.). http://www.who.int/nutrition/publications/hivaids/9241591234/en/index.html.
33. Cames C., Mouquet-Rivier C., Traore T., et al. A sustainable food support for non-breastfed infants: implementation and acceptability within a WHO mother-to-child-transmission prevention trial in Burkina Faso. Public Health Nutr 2010, 13(6):779-786.
34. Fawzi W.W., Msamanga G.I., Spiegelman D., et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998, 351(9114):1477-1482.
35. Lallemant M., Jourdain G., Le Coeur S., et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004, 351(3):217-228.
36. Arendt V., Ndimubanzi P., Vyankandondera J., et al. Effectiveness of antiretroviral therapy in breastfeeding mothers to prevent post-natal vertical transmission of HIV in Rwanda. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sidney 2007, (Abstract TUAX102).
37. Kilewo C., Karlsson K., Ngarina M., et al. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defic Syndr 2009, 52(3):406-416.
38. Palombi L., Marazzi M.C., Voetberg A., Magid N.A. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 2007, 21(Suppl 4):S65-S71.
39. Moher D., Schulz K.F., Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001, 357(9263):1191-1194.
40. Alioum A., Dabis F., Dequae-Merchadou L., et al. Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med 2001, 20(23):3539-3556.
41. Gaillard P., Piwoz E., Farley T.M. Collection of standardized information on infant feeding in the context of mother-to-child transmission of HIV. Stat Med 2001, 20(23):3525-3537.
42. Mandelbrot L., Msellati P., Meda N., et al. 15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery. Sex Transm Infect 2002, 78(4):267-270.
43. Gaillard P., Mwanyumba F., Verhofstede C., et al. Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya. AIDS 2001, 15(3):389-396.
44. Temmerman M., Quaghebeur A., Mwanyumba F., Mandaliya K. Mother-to-child HIV transmission in resource poor settings: how to improve coverage?. AIDS 2003, 17(8):1239-1242.
45. Coovadia H.M., Rollins N.C., Bland R.M., et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6months of life: an intervention cohort study. Lancet 2007, 369(9567):1107-1116.
46. Harmonized Tripartite Guidelines for Good Clinical Practice E6 (R1). International Conference on Harmonisation (ICH) 1996, http://www.ich.org/LOB/media/MEDIA482.pdf.
47. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Handbook Good Laboratory Practice (GLP) 2001, http://www.who.int/tdr/publications/publications/glp-handbook.htm.
48. Manigart O., Crepin M., Leroy V., et al. Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission. J Infect Dis 2004, 190(8):1422-1428.